Latest filing published 18 May 2009 for Dexcom Inc, €2,406.
Insider track record
No signal scores available.
Closed purchases
Based on 18 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +121.7%Entry US$1.15 · Close at T+365 US$2.56
- +250.0%Entry US$0.50 · Close at T+365 US$1.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Claudia Graham: trading record in brief
Claudia Graham discloses dealings in Dexcom Inc to SEC (Form 4). We count 18 filings; the first trade dates from 20 November 2008 and the latest from 15 May 2009.
On the market, this insider has only ever bought: 18 purchases, €28k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2009, the count stands at 5 purchases and no sales.
The median purchase comes to €1,279. After 18 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +108.5%. These figures describe past trades and do not predict future prices.
Most recently, on 18 May 2009, the filings show an open-market purchase worth €2,406 in Dexcom Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Claudia Graham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 800 shares@ US$4.06Common StockSEC:0001093557-09-000010:0Canonical exit: 13 Aug 2009 (T+90)
- 600 shares@ US$4.07Common StockSEC:0001093557-09-000010:1Canonical exit: 13 Aug 2009 (T+90)
- 581 shares@ US$4.08Common StockSEC:0001093557-09-000010:2Canonical exit: 13 Aug 2009 (T+90)
- 400 shares@ US$4.09Common StockSEC:0001093557-09-000010:3Canonical exit: 13 Aug 2009 (T+90)
- 119 shares@ US$4.10Common StockSEC:0001093557-09-000010:4Canonical exit: 13 Aug 2009 (T+90)
- 5,500 shares@ US$1.65Common StockSEC:0001093557-08-000034:0Canonical exit: 18 Feb 2009 (T+90)
- 100 shares@ US$1.67Common StockSEC:0001093557-08-000034:1Canonical exit: 18 Feb 2009 (T+90)
- 400 shares@ US$1.68Common StockSEC:0001093557-08-000034:2Canonical exit: 18 Feb 2009 (T+90)
- 200 shares@ US$1.69Common StockSEC:0001093557-08-000034:3Canonical exit: 18 Feb 2009 (T+90)
- 100 shares@ US$1.70Common StockSEC:0001093557-08-000034:4Canonical exit: 18 Feb 2009 (T+90)
- 500 shares@ US$1.71Common StockSEC:0001093557-08-000034:5Canonical exit: 18 Feb 2009 (T+90)
- 300 shares@ US$1.72Common StockSEC:0001093557-08-000034:6Canonical exit: 18 Feb 2009 (T+90)
- 1,900 shares@ US$1.73Common StockSEC:0001093557-08-000034:7Canonical exit: 18 Feb 2009 (T+90)
- 1,600 shares@ US$1.49Common StockSEC:0001093557-08-000034:8Canonical exit: 19 Feb 2009 (T+90)
- 2,000 shares@ US$1.50Common StockSEC:0001093557-08-000034:9Canonical exit: 19 Feb 2009 (T+90)
- 400 shares@ US$1.51Common StockSEC:0001093557-08-000034:10Canonical exit: 19 Feb 2009 (T+90)
- 1,900 shares@ US$1.52Common StockSEC:0001093557-08-000034:11Canonical exit: 19 Feb 2009 (T+90)
- 1,100 shares@ US$1.54Common StockSEC:0001093557-08-000034:12Canonical exit: 19 Feb 2009 (T+90)
18 of 18 declarations